Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019

Esther Kissling (1) , Angela Rose (1) , Hanne-Dorthe Emborg (2) , Alin Gherasim (3) , Richard Pebody (4) , Francisco Pozo (3) , Ramona Trebbien , Clara Mazagatos , Heather Whitaker (4) , Marta Valenciano (1)

1 EpiConcept [Paris]
2 Statens Serum Institut [Copenhagen]
3 ISC - Instituto de Salud Carlos III [Madrid]
4 Public Health England [London]

Keywords: Europe; influenza; multicentre study; test-negative design; vaccination; vaccine effectiveness; vaccines and immunisation

Domains: Life Sciences [q-bio]

Esther Kissling, Angela Rose, Hanne-Dorthe Emborg, Alin Gherasim, Richard Pebody, et al.. Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019. Eurosurveillance, 2019, 24 (8), pp.21. ⟨10.2807/1560-7917.ES.2019.24.1900121⟩. ⟨hal-02355359⟩